We hypothesized that applying this exon skipping therapy for XLAS would be possible because this disease also shows a strong genotype-phenotype correlation as observed for DMD. The gene discussed is DMD; the disease is X-linked hydrocephalus with stenosis of the aqueduct of Sylvius.